Listed by the USPTO as ANGELL, JON E
Tech Center 1600 • Art Units: 1635 1637 1641 1642 1674
This examiner grants 71% of resolved cases
ANGELL, JON E is assigned to Tech Center 1600 and Art Unit 1635. The profile includes 831 resolved cases, a 71.1% allowance rate, and a median of 1197 days to allowance. Interviews are associated with a 21.0% lift in the measured outcome.
The listed companies are Boehringer Ingelheim International GmbH, Fujifilm Corporation, and Therorna Inc. The listed firms are FOLEY & LARDNER LLP, BAKER BOTTS L.L.P., and DUANE MORRIS LLP - Boca Raton. The case volume supports using the allowance result as a practical planning reference. The median timing supports attention to examination calendars, and the interview measure supports focused discussions where they can clarify technical distinctions or claim scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18192108 | DOUBLE-STRANDED RNA THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND PHARMACEUTICAL COMPOSITION | Non-Final OA | FUJIFILM Corporation |
| 18145234 | MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN | Non-Final OA | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
| 17936715 | Treatment Of Psychiatric Disorders And Psychiatric Disorder-Associated MRI Phenotypes With Stabilin 1 (STAB1) Inhibitors | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 17637427 | TARGETING SLC38A2 IN PANCREATIC CANCER | Non-Final OA | New York University |
| 16971604 | ANALYSIS/DIAGNOSIS METHOD UTILIZING RNA MODIFICATION | Final Rejection | OSAKA UNIVERSITY |
| 17315987 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | Final Rejection | Georgia State University Research Foundation, Inc. |
| 17623045 | NOVEL ADP-RIBOSYL CYCLASE AND INHIBITOR THEREOF | Final Rejection | DNT Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy71.1% of resolved applications examined by Jon E Angell were allowed (831 resolved cases), compared with 51.6% across Art Unit 1635 over the last five years.
This examiner's interview lift is +21.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jon E Angell took 1,197 days on average from filing to allowance.
Jon E Angell examines applications in Art Unit 1635 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
